Your browser doesn't support javascript.
loading
Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.
Rubió-Casadevall, Jordi; Carbó-Bagué, Anna; Puigdemont, Montserrat; Osca-Gelis, Gemma; Oliveras, Gloria; Vilar-Coromina, Neus; Ferrer-Fabrega, Berta; Urban, Antoni; Llobet-Roma, Montserrat; Martín-Romero, Ferran; Perez-Bueno, Ferran; Marcos-Gragera, Rafael.
Afiliação
  • Rubió-Casadevall J; Medical Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain, Genetic Descriptive, Genetic and Prevention Epidemiology Group, Biomedical Research Institute of Girona (IDIBGI), Spain, School of Medicine, University of Girona (UdG), Spain.
  • Carbó-Bagué A; Medical Oncology Department, Catalan Institute of Oncology, Hospital Josep Trueta, Girona, Spain.
  • Puigdemont M; Genetic Descriptive, Genetic and Prevention Epidemiology Group, Biomedical Research Institute of Girona (IDIBGI), Spain, Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catalan Institute of Oncology, Girona, Spain, School of Nurs
  • Osca-Gelis G; Genetic Descriptive, Genetic and Prevention Epidemiology Group, Biomedical Research Institute of Girona (IDIBGI), Spain, Tumour Registry of University Hospital Josep Trueta, Catalan Institute of Oncology and Catalan Institute of Health, Girona, Spain.
  • Oliveras G; Pathology Department Hospital Josep Trueta, Catalan Institute of Health, Girona, Spain.
  • Vilar-Coromina N; Genetic Descriptive, Genetic and Prevention Epidemiology Group, Biomedical Research Institute of Girona (IDIBGI), Spain, School of Medicine, University of Girona (UdG), Spain, Dermatology Department, Hospital Josep Trueta, Catalan Institute of Health, Girona, Spain.
  • Ferrer-Fabrega B; Pathology Department, Girona Clinic, Spain.
  • Urban A; Pathology Department, Corporació de Salut del Maresme La Selva, Hospital Sant Jaume de Calella, Spain.
  • Llobet-Roma M; Pathology Department, Serveis de Salut Integrats Baix Empordà, Palamos Hospital, Spain.
  • Martín-Romero F; Pathology Department, Fundació Salut Emporda, Figueres Hospital, Spain.
  • Perez-Bueno F; Pathology Department Hospital Josep Trueta, Catalan Institute of Health, Girona, Spain.
  • Marcos-Gragera R; Genetic Descriptive, Genetic and Prevention Epidemiology Group, Biomedical Research Institute of Girona (IDIBGI), Spain, School of Medicine, University of Girona (UdG), Spain, Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health Government of Catalonia, Catal
Eur J Dermatol ; 31(5): 616-622, 2021 Oct 01.
Article em En | MEDLINE | ID: mdl-34789445
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Melanoma / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Melanoma / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article